Matthew J. Kling, et al. “Unveiling the Potential of Combined BET and HDAC Inhibition in MYC-Driven Medulloblastoma Treatment: A Promising Epigenetic Approach ”. Advanced Concepts in Medicine and Medical Research Vol. 12, Jan. 2024, pp. 143-65, doi:10.9734/bpi/acmmr/v12/7070E.